TFS Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,476
Closed -$500K 264
2017
Q2
$500K Buy
9,476
+5,869
+163% +$315K 0.2% 170
2017
Q1
$200K Sell
3,607
-28,199
-89% -$1.56M 0.06% 491
2016
Q4
$1.66M Sell
31,806
-5,771
-15% -$279K 0.44% 19
2016
Q3
$1.81M Buy
37,577
+13,745
+58% +$695K 0.43% 26
2016
Q2
$1.32M Sell
23,832
-12,146
-34% -$669K 0.24% 98
2016
Q1
$1.92M Sell
35,978
-71,844
-67% -$3.54M 0.28% 76
2015
Q4
$5.55M Sell
107,822
-26,820
-20% -$1.33M 0.6% 20
2015
Q3
$6.08M Buy
134,642
+25,347
+23% +$1.2M 0.59% 11
2015
Q2
$5.05M Buy
109,295
+71,884
+192% +$3.15M 0.49% 31
2015
Q1
$1.6M Buy
37,411
+14,946
+67% +$570K 0.16% 193
2014
Q4
$780K Buy
22,465
+6,650
+42% +$221K 0.07% 441
2014
Q3
$512K Sell
15,815
-19,986
-56% -$669K 0.04% 586
2014
Q2
$1.21M Buy
35,801
+12,085
+51% +$387K 0.1% 344
2014
Q1
$646K Sell
23,716
-23,521
-50% -$699K 0.04% 631
2013
Q4
$1.69M Sell
47,237
-35,150
-43% -$1.17M 0.08% 358
2013
Q3
$2.48M Sell
82,387
-260,583
-76% -$8.52M 0.11% 258
2013
Q2
$9.99M Buy
+342,970
New +$9.67M 0.42% 32

Other funds holding PBH

TFS Capital's PBH Position: Q3 2017 in Review

TFS Capital sold out of Prestige Consumer Healthcare (PBH) in Q3 2017, closing a stake of 9,476 shares — an estimated $500K sold.

TFS Capital first reported a position in PBH in Q2 2013 and held it in 17 quarters. The position peaked at $9.99M in Q2 2013. 239 funds tracked by Wall St. Rank hold PBH as of Q3 2017.

  • TFS Capital reported no remaining Prestige Consumer Healthcare position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 9,476 Prestige Consumer Healthcare shares in Q3 2017, an estimated $500K.
  • TFS Capital first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 17 quarters.
  • TFS Capital's Prestige Consumer Healthcare position peaked at $9.99M in Q2 2013.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.